© 2023 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
November 11, 2017
Article
Many patients who completed the survey felt maintenance therapy would help them buy time.
September 27, 2017
Article
Expanding surveillance after surgery from chest X-ray to follow-up with PET-CT scan did not improve overall survival (OS), researchers reported during the 2017 ESMO Congress.
September 11, 2017
Article
Keytruda (pembrolizumab) produced better overall survival (OS) rates than chemotherapy for patients with recurrent, advanced urothelial carcinoma.
February 07, 2017
Article
Patients with certain types of sarcoma may benefit from PD-1 blockades, according to a recent study.
February 03, 2017
Article
A recent trial showed that ribociclib had the similar benefits for elderly patients with breast cancer as it did for younger patients.
February 02, 2017
Article
After results from a phase 3 trial showed that Keytruda improved overall survival, it may become the next standard of care for patients with advanced urothelial carcinoma.
December 09, 2016
Article
According to results from a recent trial, patients with heavily pretreated lung cancer showed a durable response and clinical benefit with durvalumab.
December 07, 2016
Article
Icotinib greatly improved intracranial progression-free survival for patients with lung cancer who have brain metastases, according to a recent study.
December 07, 2016
Article
While Opdivo showed improved overall survival, there may be a survival risk within the first few months of taking it, according to recently presented data.
December 06, 2016
Article
Early results showed that avelumab may be a promising option for the treatment of patients with advanced lung cancer.
October 14, 2016
Article
After doing well in a phase 3 trial, Stivarga showed the potential to shift the treatment paradigm for previously treated liver cancer.
July 12, 2016
Article
Opdivo may be a promising treatment option for patients with squamous cell carcinoma of the anal canal.
November 18, 2015
Article
The dramatic and often practice-changing findings demonstrated by trials of immunotherapies in melanoma and lung cancer may soon be reflected in the treatment of bladder cancer.